Investing in Merck on the Stock Market
As one of the seven largest pharmaceutical companies in the world by revenue and market capitalization, Merck & Co., Inc., continues to be a leader in the research and development of pharmaceutical products in its quest to improve both human and animal health. In line with its goal, Merck publishes a best-selling medical reference book known as the Merck Manual of Diagnosis and Therapy, more often referred to simply as The Merck Manual, which has become an indispensable resource for anyone studying medicine. First published in 1899, The Merck Manual has been periodically updated, with the latest version being available in online multimedia formats which include audio, animation and 3D models. Other Merck publications include the Merck Index for pharmacists, the Merck Veterinary Manual, and the Merck Manual of Geriatrics.
Merck’s roots go back to a drug store in Darmstadt, Germany, owned by Friedrich Jacob Merck in 1668, and it was in 1891 that George Merck set up Merck & Co in the United States. Over the years, the company has developed and gone through a series of changes, all the while trying to remain true to its health-improving goal, despite a number of controversies (such as the much-publicized Vioxx recall) that may suggest otherwise. However, when a company is pioneering R&D in healthcare, addressing ever-evolving diseases, a margin for error exists, and Merck’s prompt and decisive response to problems has been a reflection of the high standards it upholds.
Listed on the New York Stock Exchange (MRK), Merck states on its website that ethics and transparency are cornerstones of their corporate reputation. Moreover, Merck remains dedicated to devoting time and resources in meeting the most critical health needs of consumers. Merck has earned a number of awards as an employer that ranks the needs of its employees high on its priority scale, ensuring job satisfaction, productivity and loyalty – qualities not often found in the modern workplace.